News Medical

TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally. Often diagnosed at advanced stages, the therapeutic ...
EurekAlert!

T-cell receptor repertoire analysis in the context of transarterial chemoembolization synergy with systemic therapy for hepatocellular carcinoma

The TCR repertoire provides a novel platform for investigating the modulation of the TME post-TACE and the underlying mechanisms governing tumor development and recurrence. Clarifying the distinctive ...

Immune Repertoire Sequencing Market Size to Reach USD 837.20 Million by 2033, Driven by Rapid Adoption of NGS in Oncology and Precision Medicine – SNS Insider

The growing use of immuno-oncology, advancing bioinformatics analysis, and rising investment in precision medicine are driving the immune repertoire sequencing market.Austin, Texas, Jan. 22, 2026 ...
GEN

Single-Cell and TCR Sequencing Reveal T Cell Biomarker in Tumor-Bearing Mice

Despite the promise of immune checkpoint therapies, treatment-resistant cancers remain a stubborn frontier, making it difficult to predict treatment responsiveness and optimize treatment protocols. A ...
Morningstar

Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease

Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The ...